# VSV-ZEBOV Geneva Vaccine Trial

> **NCT02287480** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 115 (actual)

## Conditions studied

- Ebolavirus Disease

## Interventions

- **BIOLOGICAL:** VSV-ZEBOV

## Key facts

- **NCT ID:** NCT02287480
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-04
- **Final completion:** 2016-01
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287480, "VSV-ZEBOV Geneva Vaccine Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02287480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*